Cargando…

Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing Pseudomonas aeruginosa

BACKGROUND: Carbapenem-resistant Pseudomonas aeruginosa (CrPA) is a leading cause of healthcare-associated urinary tract infections (UTIs). Carbapenemase production is an important mechanism that significantly alters the efficacy of frequently used anti-pseudomonal agents. Reporting the current geno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Seri, Jeon, Kibum, Lee, Nuri, Park, Min-Jeong, Song, Wonkeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2024
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485864/ https://www.ncbi.nlm.nih.gov/pubmed/37665284 http://dx.doi.org/10.3343/alm.2024.44.1.38

Ejemplares similares

Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated From Rectal and Clinical Samples in Korean University Hospitals Between 2016 and 2019
por: Jeong, Seri, et al.
Publicado: (2022)

Evaluation of the BD Phoenix CPO Detect Panel for Detection and Classification of Carbapenemase Producing Enterobacterales
por: Lade, Harshad, et al.
Publicado: (2023)

Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer
por: Lee, Nuri, et al.
Publicado: (2020)

Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
por: Jeong, Seri, et al.
Publicado: (2021)

Immature granulocyte percentage for prediction of sepsis in severe burn patients: a machine leaning-based approach
por: Jeon, Kibum, et al.
Publicado: (2021)

Development and validation of a deep learning-based protein electrophoresis classification algorithm
por: Lee, Nuri, et al.
Publicado: (2022)

Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
por: Lee, Nuri, et al.
Publicado: (2022)

Mobile Carbapenemase Genes in Pseudomonas aeruginosa
por: Yoon, Eun-Jeong, et al.
Publicado: (2021)

Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections
por: Jeon, Kibum, et al.
Publicado: (2022)

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
por: Tenover, Fred C., et al.
Publicado: (2022)

Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea
por: Jeong, Seri, et al.
Publicado: (2022)

Combined Use of the Modified Hodge Test and Carbapenemase Inhibition Test for Detection of Carbapenemase-Producing Enterobacteriaceae and Metallo-β-Lactamase-Producing Pseudomonas spp.
por: Song, Wonkeun, et al.
Publicado: (2015)

Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing Pseudomonas aeruginosa
por: Wang, Min-Ge, et al.
Publicado: (2021)

Dialysis Water Supply Faucet as Reservoir for Carbapenemase-Producing Pseudomonas aeruginosa
por: Prestel, Christopher, et al.
Publicado: (2022)

Detection of carbapenemase-producing Pseudomonas aeruginosa by phenotypic and genotypic methods in a tertiary care hospital of East India
por: Verma, Nishu, et al.
Publicado: (2019)

Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Correa-León, Yoselin Paola, et al.
Publicado: (2023)

Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosa
por: Gill, Christian M., et al.
Publicado: (2020)

The Rapid Carbapenemase Detection Method (rCDM) for Rapid and Accurate Detection of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
por: Jing, Xiaopeng, et al.
Publicado: (2019)

Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay
por: Song, Wonkeun, et al.
Publicado: (2020)

Immune-checkpoint proteins, cytokines, and microbiome impact on patients with cervical insufficiency and preterm birth
por: Jeong, Seri, et al.
Publicado: (2023)

First report of Klebsiella pneumonia carbapenemase-producing Pseudomonas aeruginosa isolated from burn patients in Iran: phenotypic and genotypic methods
por: Lari, Abdolaziz Rastegar, et al.
Publicado: (2014)

P073: Outbreak of carbapenemase-producing Pseudomonas aeruginosa in a tertiary care hospital
por: Navarro, P, et al.
Publicado: (2013)

Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany
por: Schäfer, Elena, et al.
Publicado: (2019)

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
por: Zhu, Yiwei, et al.
Publicado: (2021)

High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria
por: Olalekan, Adesola, et al.
Publicado: (2023)

Phenotypic and genotypic detection of antibiotic resistance of Pseudomonas aeruginosa isolated from urinary tract infections
por: Abbas, Hisham A, et al.
Publicado: (2018)

Invasion and diversity in Pseudomonas aeruginosa urinary tract infections
por: Newman, JN, et al.
Publicado: (2022)

Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing
por: Gajdács, Márió
Publicado: (2020)

Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa
por: Atrissi, Jad, et al.
Publicado: (2021)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
por: Herrera-Espejo, Soraya, et al.
Publicado: (2022)

Comparison of genotypic and phenotypic antimicrobial profile in carbapenemases producing Klebsiella pneumoniae
por: Del Rio, Arcadia, et al.
Publicado: (2023)

Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity
por: Lee, Nuri, et al.
Publicado: (2021)

Deep learning application of the discrimination of bone marrow aspiration cells in patients with myelodysplastic syndromes
por: Lee, Nuri, et al.
Publicado: (2022)

Prolonged Carriage of Carbapenemase-Producing Enterobacteriaceae: Clinical Risk Factors and the Influence of Carbapenemase and Organism Types
por: Kim, Yong Kyun, et al.
Publicado: (2021)

Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa
por: Hopman, Joost, et al.
Publicado: (2019)

656. Development and Application of a Pragmatic Algorithm for the Detection of Carbapenemase-Producing Pseudomonas aeruginosa (CP-PA)
por: Gill, Christian M, et al.
Publicado: (2020)

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016)

Pseudomonas aeruginosa - Modified Hodge Test (PAE-MHT) and ChromID Carba Agar for Detection of Carbapenemase Producing Pseudomonas Aeruginosa Recovered from Clinical Specimens
por: Othman, Hala B., et al.
Publicado: (2018)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
por: Cortazzo, Venere, et al.
Publicado: (2022)

Phenotypic and genotypic within-host diversity of Pseudomonas aeruginosa urinary isolates
por: Cottalorda, Agnès, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8mjhsicehp3dpdq8hpfsu0hhjr